Cellular reprogramming: a new approach to modelling Parkinson's disease.

Cellular reprogramming: a new approach to modelling Parkinson's disease.

iPSCs (induced pluripotent stem cells) offer an unparalleled opportunity to generate and study physiologically relevant cell types in culture. iPSCs can be generated by reprogramming almost any somatic cell type using pluripotency factors such as Oct4, SOX2, Nanog and Klf4. By reprogramming cells fr...

书目详细资料
Main Authors:	Hartfield, E, Fernandes, H, Vowles, J, Cowley, S, Wade-Martins, R
格式:	Journal article
语言:	English
出版:	2012

相似书籍

Physiological characterisation of human iPS-derived dopaminergic neurons
由: Hartfield, E, et al.
出版: (2014)

Physiological characterisation of human iPS-derived dopaminergic neurons
由: Hartfield, E, et al.
出版: (2014)

Parkinson's disease in a dish - Using stem cells as a molecular tool.
由: Badger, J, et al.
出版: (2014)

Parkinson's disease in a dish - Using stem cells as a molecular tool
由: Badger, J, et al.
出版: (2014)

Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson's iPSC-derived dopamine neurons
由: Zambon, F, et al.
出版: (2019)

Protein-protein interaction networks identify targets which rescue the MPP+ cellular model of Parkinson's disease
由: Keane, H, et al.
出版: (2015)

Variant U1 snRNAs are implicated in human pluripotent stem cell maintenance and neuromuscular disease.
由: Vazquez-Arango, P, et al.
出版: (2016)

Physiological characterisation of human iPS-derived dopaminergic neurons.
由: Elizabeth M Hartfield, et al.
出版: (2014-01-01)

Transcriptomic profiling of purified patient-derived dopamine neurons identifies convergent perturbations and therapeutics for Parkinson's disease.
由: Sandor, C, et al.
出版: (2017)

Cell reprogramming therapy for Parkinson’s disease
由: Wenjing Dong, et al.
出版: (2024-01-01)

ER stress and autophagic perturbations lead to elevated extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-derived dopamine neurons
由: Fernandes, H, et al.
出版: (2016)

Cellular reprogramming for understanding and treating human disease.
由: Riya Rajan Kanherkar, et al.
出版: (2014-11-01)

Neuroprotective Effects of Cryptotanshinone in a Direct Reprogramming Model of Parkinson’s Disease
由: Joo-Eun Lee, et al.
出版: (2020-08-01)

Epigenetic Dynamics in Reprogramming to Dopaminergic Neurons for Parkinson's Disease
由: Byounggook Cho, et al.
出版: (2024-11-01)

Astrocyte-to-neuron reprogramming and crosstalk in the treatment of Parkinson's disease
由: Yiming Wang, et al.
出版: (2023-08-01)

Commentary: Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models
由: Fernandes, H, et al.
出版: (2017)

Are rodent models of Parkinson's disease behaving as they should?
由: Vingill, S, et al.
出版: (2017)

Cellular Reprogramming and Its Potential Application in Alzheimer’s Disease
由: Chao Zhou, et al.
出版: (2022-04-01)

Network pharmacology of the MPP+ cellular model of Parkinson’s disease
由: Keane, H
出版: (2015)

RNA sequencing reveals MMP2 and TGFB1 downregulation in LRRK2 G2019S Parkinson's iPSC-derived astrocytes
由: Booth, H, et al.
出版: (2019)

Programming and reprogramming cellular identity
由: Marson, Alexander
出版: (2008)

Re: Epigenetics of Cellular Reprogramming
由: Fehmi Narter
出版: (2016-12-01)

Deterministic versus stochastic model of reprogramming: new evidence from cellular barcoding technique
由: Anastasia M. Yunusova, et al.
出版: (2017-01-01)

Convergent pathways in Parkinson’s disease
由: Cherubini, M, et al.
出版: (2017)

Advances in Cellular Reprogramming-Based Approaches for Heart Regenerative Repair
由: Xingyu He, et al.
出版: (2022-12-01)

Potential cellular and regenerative approaches for the treatment of Parkinson&rsquo;s disease
由: Emma L Lane, et al.
出版: (2008-08-01)

Cellular Reprogramming toward the Erythroid Lineage
由: Laura J. Norton, et al.
出版: (2011-01-01)

Single-cell sequencing of iPSC-dopamine neurons reconstructs disease progression and identifies HDAC4 as a regulator of Parkinson cell phenotypes
由: Lang, C, et al.
出版: (2018)

Epigenetic reprogramming shapes the cellular landscape of schwannoma
由: S. John Liu, et al.
出版: (2024-01-01)

Epigenetic determinants of cellular differentiation, transcriptional reprogramming, and human disease
由: Nguyen, Khoi Thien.
出版: (2021)

The Importance of Ubiquitination and Deubiquitination in Cellular Reprogramming
由: Bharathi Suresh, et al.
出版: (2016-01-01)

Dynamical systems theory of cellular reprogramming
由: Yuuki Matsushita, et al.
出版: (2022-04-01)

Cellular programming and reprogramming - Methods and protocols
由: CarloAlberto Redi
出版: (2010-12-01)

Implications of Cellular Aging in Cardiac Reprogramming
由: Fabiana Passaro, et al.
出版: (2018-04-01)

Neuroregeneration using in vivo cellular reprogramming
由: Tu Nguyen, et al.
出版: (2017-01-01)

The role of astrocyte dysfunction in Parkinson's disease pathogenesis
由: Booth, H, et al.
出版: (2017)

Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease.
由: Beevers, J, et al.
出版: (2013)

Parkinson’s Disease in a Dish: What Patient Specific-Reprogrammed Somatic Cells Can Tell Us about Parkinson’s Disease, If Anything?
由: J. Drouin-Ouellet, et al.
出版: (2012-01-01)

Exploring the Mitochondrial Degradome by the TAILS Proteomics Approach in a Cellular Model of Parkinson’s Disease
由: Marta Lualdi, et al.
出版: (2019-07-01)

New roles of glycosaminoglycans in α-synuclein aggregation in a cellular model of Parkinson disease.
由: Sonia Lehri-Boufala, et al.
出版: (2015-01-01)